Picture of Biomerica logo

BMRA Biomerica Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+5.18%
3m+4.52%
6m-17.6%
1yr-10.06%
Volume Change (%)
10d/3m-66.64%
Price vs... (%)
52w High-55.15%
50d MA+7.56%
200d MA-15.04%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)82.75
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.36
Price to Tang. Book4.54
Price to Free Cashflow16.67
Price to Sales2.91
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-48.44%
Return on Equity-51.52%
Operating Margin-35.98%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st May 202231st May 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biomerica EPS forecast chart

Profile Summary

Biomerica, Inc., (Biomerica) is a biomedical technology company. The Company develops, patents, manufactures and markets diagnostic and therapeutic products for the early detection and monitoring of chronic diseases and other medical conditions. The Company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications, by measuring or detecting the of specific bacteria, hormones, antibodies, antigens, or other substances, in a patient body, stools, or blood, saliva or nasal fluid. The Company is engaged in research and development of disruptive, patented diagnostic guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases.

Directors

Last Annual
May 31st, 2021
Last Interim
February 28th, 2022
Incorporated
September 22nd, 1971
Public Since
March 23rd, 2009
No. of Shareholders
800
No. of Employees
49
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
12,851,924
Blurred out image of a map
Address
17571 von Karman Ave, IRVINE, 92614-6207
Web
http://www.biomerica.com/
Phone
+1 9496452111
Auditors
PKF Certified Public Accountants

BMRA Share Price Performance

Upcoming Events for BMRA

Q4 2022 Biomerica Inc Earnings Release

Q1 2023 Biomerica Inc Earnings Release

Biomerica Inc Annual Shareholders Meeting

Q2 2023 Biomerica Inc Earnings Release

Similar to BMRA

Picture of Accelerate Diagnostics logo

Accelerate Diagnostics

us flag iconNASDAQ Capital Market

Picture of Adapthealth logo

Adapthealth

us flag iconNASDAQ Capital Market

Picture of Aethlon Medical logo

Aethlon Medical

us flag iconNASDAQ Capital Market

Picture of Agendia NV logo

Agendia NV

us flag iconNASDAQ Capital Market

Picture of Allied Healthcare Products logo

Allied Healthcare Products

us flag iconNASDAQ Capital Market

FAQ

Or unlock with your email

Or unlock with your email